Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3085 to 3096 of 3128 entries
Sorted by: Best Match Show Resources per page
Using Emergency Medical Services Data to Monitor Nonfatal Opioid Overdoses in Real Time : Development, Validation, and Use of a Case Definition, Rhode Island, 2018.

Public health reports (Washington, D.C. : 1974)

Hallowell BD, Chambers LC, Rhodes J, Basta M, Viner-Brown S, Lasher L.
PMID: 34726979
Public Health Rep. 2021 Nov-Dec;136(1):40S-46S. doi: 10.1177/00333549211018989.

OBJECTIVE: No case definition exists that allows public health authorities to accurately identify opioid overdoses using emergency medical services (EMS) data. We developed and evaluated a case definition for suspected nonfatal opioid overdoses in EMS data.METHODS: To identify suspected...

Cite
Hallowell BD, Chambers LC, Rhodes J, et al. Using Emergency Medical Services Data to Monitor Nonfatal Opioid Overdoses in Real Time : Development, Validation, and Use of a Case Definition, Rhode Island, 2018. Public Health Rep. 2021;136(1):40S-46Sdoi: 10.1177/00333549211018989.
Hallowell, B. D., Chambers, L. C., Rhodes, J., Basta, M., Viner-Brown, S., & Lasher, L. (2021). Using Emergency Medical Services Data to Monitor Nonfatal Opioid Overdoses in Real Time : Development, Validation, and Use of a Case Definition, Rhode Island, 2018. Public health reports (Washington, D.C. : 1974), 136(1), 40S-46S. https://doi.org/10.1177/00333549211018989
Hallowell, Benjamin D, et al. "Using Emergency Medical Services Data to Monitor Nonfatal Opioid Overdoses in Real Time : Development, Validation, and Use of a Case Definition, Rhode Island, 2018." Public health reports (Washington, D.C. : 1974) vol. 136,1 (2021): 40S-46S. doi: https://doi.org/10.1177/00333549211018989
Hallowell BD, Chambers LC, Rhodes J, Basta M, Viner-Brown S, Lasher L. Using Emergency Medical Services Data to Monitor Nonfatal Opioid Overdoses in Real Time : Development, Validation, and Use of a Case Definition, Rhode Island, 2018. Public Health Rep. 2021 Nov-Dec;136(1):40S-46S. doi: 10.1177/00333549211018989. PMID: 34726979.
Copy Download .nbib Format: NLM
Spatiotemporal Analysis of the Association Between Pain Management Clinic Laws and Opioid Prescribing and Overdose Deaths.

American journal of epidemiology

Cerdá M, Wheeler-Martin K, Bruzelius E, Ponicki W, Gruenewald P, Mauro C, Crystal S, Davis CS, Keyes K, Hasin D, Rudolph KE, Martins SS.
PMID: 34216209
Am J Epidemiol. 2021 Dec 01;190(12):2592-2603. doi: 10.1093/aje/kwab192.

Pain management clinic (PMC) laws were enacted by 12 states to promote appropriate opioid prescribing, but their impact is inadequately understood. We analyzed county-level opioid overdose deaths (National Vital Statistics System) and patients filling long-duration (≥30 day) or high-dose...

Cite
Cerdá M, Wheeler-Martin K, Bruzelius E, et al. Spatiotemporal Analysis of the Association Between Pain Management Clinic Laws and Opioid Prescribing and Overdose Deaths. Am J Epidemiol. 2021;190(12):2592-2603doi: 10.1093/aje/kwab192.
Cerdá, M., Wheeler-Martin, K., Bruzelius, E., Ponicki, W., Gruenewald, P., Mauro, C., Crystal, S., Davis, C. S., Keyes, K., Hasin, D., Rudolph, K. E., & Martins, S. S. (2021). Spatiotemporal Analysis of the Association Between Pain Management Clinic Laws and Opioid Prescribing and Overdose Deaths. American journal of epidemiology, 190(12), 2592-2603. https://doi.org/10.1093/aje/kwab192
Cerdá, Magdalena, et al. "Spatiotemporal Analysis of the Association Between Pain Management Clinic Laws and Opioid Prescribing and Overdose Deaths." American journal of epidemiology vol. 190,12 (2021): 2592-2603. doi: https://doi.org/10.1093/aje/kwab192
Cerdá M, Wheeler-Martin K, Bruzelius E, Ponicki W, Gruenewald P, Mauro C, Crystal S, Davis CS, Keyes K, Hasin D, Rudolph KE, Martins SS. Spatiotemporal Analysis of the Association Between Pain Management Clinic Laws and Opioid Prescribing and Overdose Deaths. Am J Epidemiol. 2021 Dec 01;190(12):2592-2603. doi: 10.1093/aje/kwab192. PMID: 34216209.
Copy Download .nbib Format: NLM
Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.

Circulation

Franklin JM, Patorno E, Desai RJ, Glynn RJ, Martin D, Quinto K, Pawar A, Bessette LG, Lee H, Garry EM, Gautam N, Schneeweiss S.
PMID: 33327727
Circulation. 2021 Mar 09;143(10):1002-1013. doi: 10.1161/CIRCULATIONAHA.120.051718. Epub 2020 Dec 17.

BACKGROUND: Regulators are evaluating the use of noninterventional real-world evidence (RWE) studies to assess the effectiveness of medical products. The RCT DUPLICATE initiative (Randomized, Controlled Trials Duplicated Using Prospective Longitudinal Insurance Claims: Applying Techniques of Epidemiology) uses a structured...

Cite
Franklin JM, Patorno E, Desai RJ, et al. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative. Circulation. 2020;143(10):1002-1013doi: 10.1161/CIRCULATIONAHA.120.051718.
Franklin, J. M., Patorno, E., Desai, R. J., Glynn, R. J., Martin, D., Quinto, K., Pawar, A., Bessette, L. G., Lee, H., Garry, E. M., Gautam, N., & Schneeweiss, S. (2021). Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative. Circulation, 143(10), 1002-1013. https://doi.org/10.1161/CIRCULATIONAHA.120.051718
Franklin, Jessica M, et al. "Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative." Circulation vol. 143,10 (2021): 1002-1013. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.051718
Franklin JM, Patorno E, Desai RJ, Glynn RJ, Martin D, Quinto K, Pawar A, Bessette LG, Lee H, Garry EM, Gautam N, Schneeweiss S. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative. Circulation. 2021 Mar 09;143(10):1002-1013. doi: 10.1161/CIRCULATIONAHA.120.051718. Epub 2020 Dec 17. PMID: 33327727; PMCID: PMC7940583.
Copy Download .nbib Format: NLM
Engaging stakeholders in the refinement of an evidence-based remotely delivered epilepsy self-management program for rural populations.

Epilepsy & behavior : E&B

Blixen C, Ghearing G, Wade O, Colon-Zimmerman K, Tyrrell M, Sajatovic M.
PMID: 33845345
Epilepsy Behav. 2021 May;118:107942. doi: 10.1016/j.yebeh.2021.107942. Epub 2021 Apr 10.

A growing body of research supports self-management approaches that can improve outcomes in people living with epilepsy (PLWE). An evidence-based remotely delivered self-management program (SMART) that was successfully delivered in an urban/suburban setting has the potential to be particularly...

Cite
Blixen C, Ghearing G, Wade O, et al. Engaging stakeholders in the refinement of an evidence-based remotely delivered epilepsy self-management program for rural populations. Epilepsy Behav. 2021;118:107942doi: 10.1016/j.yebeh.2021.107942.
Blixen, C., Ghearing, G., Wade, O., Colon-Zimmerman, K., Tyrrell, M., & Sajatovic, M. (2021). Engaging stakeholders in the refinement of an evidence-based remotely delivered epilepsy self-management program for rural populations. Epilepsy & behavior : E&B, 118107942. https://doi.org/10.1016/j.yebeh.2021.107942
Blixen, Carol, et al. "Engaging stakeholders in the refinement of an evidence-based remotely delivered epilepsy self-management program for rural populations." Epilepsy & behavior : E&B vol. 118 (2021): 107942. doi: https://doi.org/10.1016/j.yebeh.2021.107942
Blixen C, Ghearing G, Wade O, Colon-Zimmerman K, Tyrrell M, Sajatovic M. Engaging stakeholders in the refinement of an evidence-based remotely delivered epilepsy self-management program for rural populations. Epilepsy Behav. 2021 May;118:107942. doi: 10.1016/j.yebeh.2021.107942. Epub 2021 Apr 10. PMID: 33845345; PMCID: PMC8107125.
Copy Download .nbib Format: NLM
Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Lentine KL, Salvalaggio PR, Caliskan Y, Lam NN, McAdams-DeMarco M, Axelrod D, Segev DL, Myaskovsky L, Dew MA, Bruschwein H, Levine DJ, Sweet S, Hess GP, Kasiske BL, Schnitzler MA.
PMID: 33846078
J Heart Lung Transplant. 2021 Jun;40(6):513-524. doi: 10.1016/j.healun.2021.02.004. Epub 2021 Feb 17.

BACKGROUND: Prescription opioid and benzodiazepine use have been associated with morbidity and mortality among some groups of solid organ transplant recipients, but implications for outcomes among lung transplant patients are not well described.METHODS: We conducted a retrospective cohort study...

Cite
Lentine KL, Salvalaggio PR, Caliskan Y, et al. Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records. J Heart Lung Transplant. 2021;40(6):513-524doi: 10.1016/j.healun.2021.02.004.
Lentine, K. L., Salvalaggio, P. R., Caliskan, Y., Lam, N. N., McAdams-DeMarco, M., Axelrod, D., Segev, D. L., Myaskovsky, L., Dew, M. A., Bruschwein, H., Levine, D. J., Sweet, S., Hess, G. P., Kasiske, B. L., & Schnitzler, M. A. (2021). Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 40(6), 513-524. https://doi.org/10.1016/j.healun.2021.02.004
Lentine, Krista L, et al. "Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 40,6 (2021): 513-524. doi: https://doi.org/10.1016/j.healun.2021.02.004
Lentine KL, Salvalaggio PR, Caliskan Y, Lam NN, McAdams-DeMarco M, Axelrod D, Segev DL, Myaskovsky L, Dew MA, Bruschwein H, Levine DJ, Sweet S, Hess GP, Kasiske BL, Schnitzler MA. Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records. J Heart Lung Transplant. 2021 Jun;40(6):513-524. doi: 10.1016/j.healun.2021.02.004. Epub 2021 Feb 17. PMID: 33846078; PMCID: PMC8169588.
Copy Download .nbib Format: NLM
Comparing Pediatric Gastroenteritis Emergency Department Care in Canada and the United States.

Pediatrics

Freedman SB, Roskind CG, Schuh S, VanBuren JM, Norris JG, Tarr PI, Hurley K, Levine AC, Rogers A, Bhatt S, Gouin S, Mahajan P, Vance C, Powell EC, Farion KJ, Sapien R, O'Connell K, Poonai N, Schnadower D.
PMID: 34016656
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-030890. Epub 2021 May 20.

BACKGROUND: Between-country variation in health care resource use and its impact on outcomes in acute care settings have been challenging to disentangle from illness severity by using administrative data.METHODS: We conducted a preplanned analysis employing patient-level emergency department (ED)...

Cite
Freedman SB, Roskind CG, Schuh S, et al. Comparing Pediatric Gastroenteritis Emergency Department Care in Canada and the United States. Pediatrics. 2021;147(6)doi: 10.1542/peds.2020-030890.
Freedman, S. B., Roskind, C. G., Schuh, S., VanBuren, J. M., Norris, J. G., Tarr, P. I., Hurley, K., Levine, A. C., Rogers, A., Bhatt, S., Gouin, S., Mahajan, P., Vance, C., Powell, E. C., Farion, K. J., Sapien, R., O'Connell, K., Poonai, N., Schnadower, D. (2021). Comparing Pediatric Gastroenteritis Emergency Department Care in Canada and the United States. Pediatrics, 147(6), . https://doi.org/10.1542/peds.2020-030890
Freedman, Stephen B, et al. "Comparing Pediatric Gastroenteritis Emergency Department Care in Canada and the United States." Pediatrics vol. 147,6 (2021). doi: https://doi.org/10.1542/peds.2020-030890
Freedman SB, Roskind CG, Schuh S, VanBuren JM, Norris JG, Tarr PI, Hurley K, Levine AC, Rogers A, Bhatt S, Gouin S, Mahajan P, Vance C, Powell EC, Farion KJ, Sapien R, O'Connell K, Poonai N, Schnadower D. Comparing Pediatric Gastroenteritis Emergency Department Care in Canada and the United States. Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-030890. Epub 2021 May 20. PMID: 34016656.
Copy Download .nbib Format: NLM
Field epidemiology training programs contribute to COVID-19 preparedness and response globally.

BMC public health

Hu AE, Fontaine R, Turcios-Ruiz R, Abedi AA, Williams S, Hilmers A, Njoh E, Bell E, Reddy C, Ijaz K, Baggett HC.
PMID: 35012482
BMC Public Health. 2022 Jan 10;22(1):63. doi: 10.1186/s12889-021-12422-z.

BACKGROUND: Field epidemiology training programs (FETPs) have trained field epidemiologists who strengthen global capacities for surveillance and response to public health threats. We describe how FETP residents and graduates have contributed to COVID-19 preparedness and response globally.METHODS: We conducted...

Cite
Hu AE, Fontaine R, Turcios-Ruiz R, et al. Field epidemiology training programs contribute to COVID-19 preparedness and response globally. BMC Public Health. 2022;22(1):63doi: 10.1186/s12889-021-12422-z.
Hu, A. E., Fontaine, R., Turcios-Ruiz, R., Abedi, A. A., Williams, S., Hilmers, A., Njoh, E., Bell, E., Reddy, C., Ijaz, K., & Baggett, H. C. (2022). Field epidemiology training programs contribute to COVID-19 preparedness and response globally. BMC public health, 22(1), 63. https://doi.org/10.1186/s12889-021-12422-z
Hu, Audrey E, et al. "Field epidemiology training programs contribute to COVID-19 preparedness and response globally." BMC public health vol. 22,1 (2022): 63. doi: https://doi.org/10.1186/s12889-021-12422-z
Hu AE, Fontaine R, Turcios-Ruiz R, Abedi AA, Williams S, Hilmers A, Njoh E, Bell E, Reddy C, Ijaz K, Baggett HC. Field epidemiology training programs contribute to COVID-19 preparedness and response globally. BMC Public Health. 2022 Jan 10;22(1):63. doi: 10.1186/s12889-021-12422-z. PMID: 35012482.
Copy Download .nbib Format: NLM
Smoking Susceptibility and Tobacco Media Engagement Among Youth Never Smokers.

Pediatrics

Coreas SI, Rodriquez EJ, Rahman SG, El-Toukhy S, Compton WM, Blanco C, Kimmel HL, Pérez-Stable EJ.
PMID: 33941582
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-017921. Epub 2021 May 03.

BACKGROUND: Susceptibility to future smoking among youth never smokers has not changed in the past 20 years, although experimental cigarette smoking has decreased. We assessed how smoking susceptibility and tobacco industry-related marketing influenced smoking initiation.METHODS: Four waves (2013-2018) of...

Cite
Coreas SI, Rodriquez EJ, Rahman SG, et al. Smoking Susceptibility and Tobacco Media Engagement Among Youth Never Smokers. Pediatrics. 2021;147(6)doi: 10.1542/peds.2020-017921.
Coreas, S. I., Rodriquez, E. J., Rahman, S. G., El-Toukhy, S., Compton, W. M., Blanco, C., Kimmel, H. L., & Pérez-Stable, E. J. (2021). Smoking Susceptibility and Tobacco Media Engagement Among Youth Never Smokers. Pediatrics, 147(6), . https://doi.org/10.1542/peds.2020-017921
Coreas, Saida I, et al. "Smoking Susceptibility and Tobacco Media Engagement Among Youth Never Smokers." Pediatrics vol. 147,6 (2021). doi: https://doi.org/10.1542/peds.2020-017921
Coreas SI, Rodriquez EJ, Rahman SG, El-Toukhy S, Compton WM, Blanco C, Kimmel HL, Pérez-Stable EJ. Smoking Susceptibility and Tobacco Media Engagement Among Youth Never Smokers. Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-017921. Epub 2021 May 03. PMID: 33941582; PMCID: PMC8331193.
Copy Download .nbib Format: NLM
A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California.

JAMA pediatrics

Friedman AS.
PMID: 34028507
JAMA Pediatr. 2021 Aug 01;175(8):863-865. doi: 10.1001/jamapediatrics.2021.0922.

No abstract available.

Cite
Friedman AS. A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California. JAMA Pediatr. 2021;175(8):863-865doi: 10.1001/jamapediatrics.2021.0922.
Friedman, A. S. (2021). A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California. JAMA pediatrics, 175(8), 863-865. https://doi.org/10.1001/jamapediatrics.2021.0922
Friedman, Abigail S. "A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California." JAMA pediatrics vol. 175,8 (2021): 863-865. doi: https://doi.org/10.1001/jamapediatrics.2021.0922
Friedman AS. A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California. JAMA Pediatr. 2021 Aug 01;175(8):863-865. doi: 10.1001/jamapediatrics.2021.0922. PMID: 34028507; PMCID: PMC8145156.
Copy Download .nbib Format: NLM
Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution.

Military medicine

Nazario-Toole AE, Xia H, Gibbons TF.
PMID: 33609027
Mil Med. 2022 Jan 04;187(1):e130-e137. doi: 10.1093/milmed/usab031.

INTRODUCTION: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a global pandemic resulting in over 1 million deaths worldwide. In the Department of Defense (DoD), over 129,000 personnel (civilians, dependents, and active duty) have been...

Cite
Nazario-Toole AE, Xia H, Gibbons TF. Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution. Mil Med. 2022;187(1):e130-e137doi: 10.1093/milmed/usab031.
Nazario-Toole, A. E., Xia, H., & Gibbons, T. F. (2022). Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution. Military medicine, 187(1), e130-e137. https://doi.org/10.1093/milmed/usab031
Nazario-Toole, Ashley E, et al. "Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution." Military medicine vol. 187,1 (2022): e130-e137. doi: https://doi.org/10.1093/milmed/usab031
Nazario-Toole AE, Xia H, Gibbons TF. Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution. Mil Med. 2022 Jan 04;187(1):e130-e137. doi: 10.1093/milmed/usab031. PMID: 33609027; PMCID: PMC7928784.
Copy Download .nbib Format: NLM
The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida.

Cancer medicine

Guo Y, Szurek SM, Bian J, Braithwaite D, Licht JD, Shenkman EA.
PMID: 34254469
Cancer Med. 2021 Sep;10(17):6048-6057. doi: 10.1002/cam4.4122. Epub 2021 Jul 13.

BACKGROUND: People's fatalistic beliefs about cancer can influence their cancer prevention behaviors. We examined the association between fatalistic beliefs and breast and colorectal cancer screening among residents of north-central Florida and tested whether there exists any sex or rural-non-rural...

Cite
Guo Y, Szurek SM, Bian J, et al. The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida. Cancer Med. 2021;10(17):6048-6057doi: 10.1002/cam4.4122.
Guo, Y., Szurek, S. M., Bian, J., Braithwaite, D., Licht, J. D., & Shenkman, E. A. (2021). The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida. Cancer medicine, 10(17), 6048-6057. https://doi.org/10.1002/cam4.4122
Guo, Yi, et al. "The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida." Cancer medicine vol. 10,17 (2021): 6048-6057. doi: https://doi.org/10.1002/cam4.4122
Guo Y, Szurek SM, Bian J, Braithwaite D, Licht JD, Shenkman EA. The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida. Cancer Med. 2021 Sep;10(17):6048-6057. doi: 10.1002/cam4.4122. Epub 2021 Jul 13. PMID: 34254469; PMCID: PMC8419763.
Copy Download .nbib Format: NLM
Hospital Use for Myocardial Infarction and Stroke Among Medicare Beneficiaries From March to December 2020.

JAMA cardiology

Stewart KA, Blue L, Kranker K, Nelson S, McCall N, Markovich P, Peterson GG.
PMID: 34347009
JAMA Cardiol. 2021 Nov 01;6(11):1340-1342. doi: 10.1001/jamacardio.2021.2729.

No abstract available.

Cite
Stewart KA, Blue L, Kranker K, et al. Hospital Use for Myocardial Infarction and Stroke Among Medicare Beneficiaries From March to December 2020. JAMA Cardiol. 2021;6(11):1340-1342doi: 10.1001/jamacardio.2021.2729.
Stewart, K. A., Blue, L., Kranker, K., Nelson, S., McCall, N., Markovich, P., & Peterson, G. G. (2021). Hospital Use for Myocardial Infarction and Stroke Among Medicare Beneficiaries From March to December 2020. JAMA cardiology, 6(11), 1340-1342. https://doi.org/10.1001/jamacardio.2021.2729
Stewart, Kate A, et al. "Hospital Use for Myocardial Infarction and Stroke Among Medicare Beneficiaries From March to December 2020." JAMA cardiology vol. 6,11 (2021): 1340-1342. doi: https://doi.org/10.1001/jamacardio.2021.2729
Stewart KA, Blue L, Kranker K, Nelson S, McCall N, Markovich P, Peterson GG. Hospital Use for Myocardial Infarction and Stroke Among Medicare Beneficiaries From March to December 2020. JAMA Cardiol. 2021 Nov 01;6(11):1340-1342. doi: 10.1001/jamacardio.2021.2729. PMID: 34347009; PMCID: PMC8339994.
Copy Download .nbib Format: NLM
Showing 3085 to 3096 of 3128 entries